Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Publication Title

European urology

Document Type

Article

Publication Date

5-21-2024

Keywords

oregon; chiles

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

DOI

10.1016/j.eururo.2024.05.003

Share

COinS